Compare NNBR & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNBR | PLX |
|---|---|---|
| Founded | 1980 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.5M | 168.4M |
| IPO Year | 1996 | 1996 |
| Metric | NNBR | PLX |
|---|---|---|
| Price | $3.50 | $2.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 4.9M | 677.8K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.60 | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | ★ $770,657,000.00 | $52,744,000.00 |
| Revenue This Year | $8.60 | $36.81 |
| Revenue Next Year | $6.30 | N/A |
| P/E Ratio | ★ N/A | $10.95 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $1.41 |
| 52 Week High | $4.44 | $3.19 |
| Indicator | NNBR | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 54.40 | 57.49 |
| Support Level | $1.31 | $2.06 |
| Resistance Level | $4.44 | $2.44 |
| Average True Range (ATR) | 0.36 | 0.09 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 31.46 | 50.00 |
NN Inc is a diversified industrial company that combines engineering and production capabilities with materials science expertise to design and manufacture high-precision components and solutions. The company operates through two segments: Mobile Solutions, which generates maximum revenue and focuses on the automotive, general industrial, and medical end markets, manufacturing tight-tolerance components used in battery electric, hybrid electric, and internal combustion engine vehicles, braking, transmissions, fuel systems, HVAC, and diesel systems; and Power Solutions, which focuses on the electrical, general industrial, automotive, medical, and aerospace and defense end markets and manufactures high-precision metal components, assemblies, contact assemblies, and precision stampings.
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.